Low-dose Recombinant Human IL-2 for the Treatment of Relapsing Polychondritis
Clinical trial NCT04077736 · COMPLETED
Trial details
- NCT number
- NCT04077736
- Sponsor
- Peking University People's Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-01
- Primary completion
- 2023-10-10
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.